Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...

The Bull Case For Abbott Laboratories (ABT) Could Change Following Dividend Hike And New AFib Device Approval

In recent weeks, Abbott Laboratories raised its quarterly dividend for the 52nd consecutive year and secured CE Mark approval ...
Modesto Bee

Abbott’s fast coronavirus test could pose safety issue for those processing results

Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded ― particularly, the risk of infection to ...
Fierce Biotech

Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings

Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw ...
The Business Journals

Abbott Labs performing well despite huge drop-off in Covid test sales

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Chicago company said ...

Abbott Labs Seen Posting Higher 4Q Sales Amid Pending Buyout of Exact Sciences -- Earnings Preview

ADJUSTED EARNINGS: Stripping out certain one-time items, earnings are forecast to come in at $1.50 a share. That compares with adjusted earnings of $1.34 a share a year earlier. REVENUE: Quarterly ...